Technical Analysis for 1AD - Adalta Ltd
Grade | Last Price | % Change | Price Change |
---|---|---|---|
B | 0.028 | 3.70% | 0.001 |
ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Strong | Up | Up | Down |
Date | Alert Name | Type | % Chg |
---|---|---|---|
Shooting Star Candlestick | Bearish | 0.00% | |
Pocket Pivot | Bullish Swing Setup | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Gapped Up | Strength | 0.00% | |
Upper Bollinger Band Touch | Strength | 0.00% | |
Boomer Buy Setup | Bullish Swing Setup | 3.70% | |
NR7 | Range Contraction | 3.70% | |
Narrow Range Bar | Range Contraction | 3.70% | |
MACD Bearish Signal Line Cross | Bearish | 3.70% | |
Boomer Buy Setup | Bullish Swing Setup | 3.70% |
Alert | Time |
---|---|
Possible Pocket Pivot | 1 day ago |
10 DMA Resistance | 1 day ago |
Upper Bollinger Band Resistance | 1 day ago |
1.5x Volume Pace | 1 day ago |
Up 10% | 1 day ago |
Get a Trading Assistant
Adalta Ltd Description
AdAlta Limited is an Australia-based drug discovery and development company. The Company is focused on using its technology platform to generate protein therapeutics, known as i-bodies, for treating a range of human diseases. The Company's principal activity is to develop its ibody platform with a focus on its lead candidate AD-114, a treatment for idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases. Its i-body AD-114 drug candidate is used for treatment in various fibrosis related eye diseases to support the pre-clinical development of the eye fibrosis indication. The Company's AD-114 has shown both anti-fibrotic and anti-inflammatory effects in various animal models. The Company's AD-114 is used in various therapeutic applications for fibrosis diseases of the liver, skin, kidney and heart. AD-114 has completed pre-clinical studies in vitro (in the lab) and in vivo (in animals) data obtained.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Chemistry Health Medicine Disease Diseases Protein Heart Animals Drug Discovery In Vitro Eye Diseases Fibrosis Fibrotic Diseases Idiopathic Pulmonary Fibrosis Pulmonary Fibrosis
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 0.048 |
52 Week Low | 0.017 |
Average Volume | 3,357,478 |
200-Day Moving Average | 0.024 |
50-Day Moving Average | 0.025 |
20-Day Moving Average | 0.027 |
10-Day Moving Average | 0.028 |
Average True Range | 0.003 |
RSI (14) | 52.61 |
ADX | 35.38 |
+DI | 46.765 |
-DI | 17.059 |
Chandelier Exit (Long, 3 ATRs) | 0.029 |
Chandelier Exit (Short, 3 ATRs) | 0.032 |
Upper Bollinger Bands | 0.031 |
Lower Bollinger Band | 0.024 |
Percent B (%b) | 0.63 |
BandWidth | 26.568 |
MACD Line | 0.001 |
MACD Signal Line | 0.001 |
MACD Histogram | -0.0001 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 0.033 | ||||
Resistance 3 (R3) | 0.033 | 0.032 | 0.032 | ||
Resistance 2 (R2) | 0.032 | 0.031 | 0.032 | 0.031 | |
Resistance 1 (R1) | 0.030 | 0.030 | 0.030 | 0.030 | 0.031 |
Pivot Point | 0.029 | 0.029 | 0.029 | 0.029 | 0.029 |
Support 1 (S1) | 0.027 | 0.028 | 0.027 | 0.027 | 0.025 |
Support 2 (S2) | 0.026 | 0.027 | 0.026 | 0.025 | |
Support 3 (S3) | 0.024 | 0.026 | 0.024 | ||
Support 4 (S4) | 0.024 |